TransMedics (TMDX) Interest Coverage Ratio Growth (1y) (2019 - 2026)
Powered by 
Analysis
TransMedics (TMDX) Interest Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -71.56% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 15.51% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 68.09% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 34.84% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -95.71% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 16.91% |
| 10 | TransMedics | 2.98 Bn | 2.51 Bn | 113.20 Mn | -68.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -68.77% |
| Mar 31, 2026 | -76.61% |
| Dec 31, 2025 | 162.02% |
| Sep 30, 2025 | 515.37% |
| Jun 30, 2025 | 204.71% |
| Mar 31, 2025 | 129.69% |
| Dec 31, 2024 | 235.24% |
| Sep 30, 2024 | 113.74% |
| Jun 30, 2024 | 1,054.55% |
| Mar 31, 2024 | 280.29% |
| Dec 31, 2023 | 110.73% |
| Sep 30, 2023 | -12.04% |
| Jun 30, 2023 | 96.39% |
| Mar 31, 2023 | 80.38% |
| Dec 31, 2022 | 41.88% |
| Sep 30, 2022 | 41.18% |
| Jun 30, 2022 | 1.96% |
| Mar 31, 2022 | -42.78% |
| Dec 31, 2021 | -90.76% |
| Sep 30, 2021 | -152.26% |